These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38783288)

  • 1. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Mechanism of Zilongjin in Treating Lung Adenocarcinoma Based on Network Pharmacology Combined with Experimental Verification.
    Zhang K; Chen X
    Crit Rev Immunol; 2024; 44(5):27-40. PubMed ID: 38618726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
    Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
    BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
    Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
    Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
    Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of Lung Cancer.
    Zhang YC; Gao WC; Chen WJ; Pang DX; Mo DY; Yang M
    Curr Pharm Des; 2023; 29(14):1121-1134. PubMed ID: 37138492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer.
    Wang R; Gao C; Yu M; Song J; Feng Z; Wang R; Pan H; Liu H; Li W; Fan X
    BMC Complement Med Ther; 2024 Jun; 24(1):214. PubMed ID: 38840248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
    Zhao XY; Yang YY; Feng JL; Feng CL
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
    Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
    Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
    Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
    Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer.
    Wu Z; Zhu Z; Fu L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4165-4181. PubMed ID: 38032489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification.
    Pan J; Yang H; Zhu L; Lou Y; Jin B
    Front Pharmacol; 2022; 13():897966. PubMed ID: 36091822
    [No Abstract]   [Full Text] [Related]  

  • 20. Network pharmacological study and in vitro studies validation-Molecular dynamics simulation of Cistanche deserticola in promoting periodontitis and bone remodeling.
    Shan C; Wu Z; Xia Y; Ji X; Zhang W; Peng X; Zhao J
    Int Immunopharmacol; 2024 Jun; 135():112299. PubMed ID: 38776853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.